Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
Esther KlaverAngela Bureo GonzalezNahid MostafaviRosalie Mallant-HentLucas C DuitsBert BaakClarisse J M BöhmerArnoud H A M van OijenTon NaberPieter ScholtenSybren L MeijerJacques J G H M BergmanR Roos E Pouwnull nullPublished in: United European gastroenterology journal (2021)
Risk of progression to HGD/EAC in a large, prospective, community-based Barrett's cohort was low. Barrett's length, LGD and age were important risk factors for progression. (www.trialregister.nl NTR1789).